StageUnattributed VC | Alive
eSight creates electronic glasses that restore or enhance sight for individuals living with vision loss. Worn comfortably like a normal pair of glasses or with prescription lenses built-in, they allow a person with low vision to see in virtually the same manner as someone who is fully-sighted can. The company's SPEX enhances vision for precision tasks, allowing users to pan and zoom the real world or streamed images, and brings critical information to the point of task without overwriting or obstructing natural vision for full situational awareness and mobility.
Missing: eSight's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: eSight's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing eSight
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned eSight in 1 CB Insights research brief, most recently on Nov 11, 2022.
Expert Collections containing eSight
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
eSight is included in 6 Expert Collections, including AR/VR.
This collection includes companies creating hardware and/or software for augmented reality, virtual reality, and mixed reality applications.
Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Smart Home & Consumer Electronics
This Collection includes companies developing smart home devices, wearables, home electronics, and other consumer electronics.
eSight has filed 31 patents.
The 3 most popular patent topics include:
Typography, Reading (process), Virtual reality, Augmented reality applications, Writing
Typography, Reading (process), Virtual reality, Augmented reality applications, Writing
Latest eSight News
Jan 3, 2023
Toronto, Ontario, CANADA TORONTO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight , today announces the launch of its latest innovation in assistive technology, eSight Go . The wearable device sets a new standard for enhanced vision technology through its heightened visual clarity, lightweight design and expansive field of view, helping those with central vision loss gain independence in their everyday life. “We’ve spent the past year vastly improving the capacity and design of our digital eyewear, not only to help enhance vision for our visually impaired users, but so they can enjoy an enriched and fulfilling livelihood in the most seamless way possible,” said eSight Director of Product Marketing Roland Mattern. “We gathered feedback from our eSight 4 users and coaches to thoughtfully craft the best device possible that is sleek, lightweight and comfortable for everyday use. We look forward to connecting with qualified candidates and changing lives for those living with central vision loss.” Used by thousands of people across the globe with over 20 different eye conditions, eSight devices use a combination of hardware and software to enhance vision through a nimble, wearable design that does not restrict a wearer’s full periphery. eSight Go is designed for 100 percent mobility retention, allowing people to use the technology while at school, work, home and enjoying time with friends and family. Comparable to eSight 4, eSight Go utilizes best-match camera and lens technology to project a superior image onto two high resolution screens for full binocular vision. eSight Go users can personalize adjustable color and contrast settings on the internal-facing OLED screens. A wider field of view (45 degrees) incorporates a user’s natural peripheral capacity to amplify existing vision for unmatched mobility. New features also include: Improved software with simplified navigation and image stabilization Higher quality camera with 12-megapixel resolution and 4k capability and full HD OLED monitors to provide users with the clearest picture possible Comfortable neck battery pack that redistributes 170 grams across the neck eSight will preview eSight Go at CES 2023 and it will be available on the market starting in Q4 2023. The device will be on display at the Gentex booth (#6341) from January 5-8, 2023. For downloadable images, videos, tech spec sheets and more, please visit here . For more information on how eSight can benefit you or someone you know, please contact an eSight Advisor by calling 1-855-8eSight (1-855-837-4448), emailing info@eSightEyewear.com or by visiting www.eSightEyewear.com . Health Care Professionals can access eSight through the eSight TeleHealth Clinical Partnership program by visiting www.esighteyewear.com/vision-professionals/ . About eSight eSight is a leading vision-platform organization with a simple but profound promise: empower individuals with sight loss to see new possibilities through enhanced vision. eSight provides the most advanced and versatile assistive device available for those with visual impairments and is compatible with more than 20 eye conditions including macular degeneration, diabetic retinopathy, and Stargardt disease. eSight is registered with the FDA and EUDAMED and is inspected by Health Canada. Learn more at www.eSightEyewear.com . A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e04449fc-e11a-4da6-a833-c94d62567678 eSight Announces Newest Generation of Assistive Device for the Legally Blind, eSight Go Previewing at CES 2023, the wearable device marks a new generation of versatile assistive devices fo...
eSight Frequently Asked Questions (FAQ)
When was eSight founded?
eSight was founded in 2006.
Where is eSight's headquarters?
eSight's headquarters is located at 1 Eglinton Ave E, Toronto.
What is eSight's latest funding round?
eSight's latest funding round is Unattributed VC.
How much did eSight raise?
eSight raised a total of $14.34M.
Who are the investors of eSight?
Investors of eSight include iGan Partners, Boston Harbor Angels, Mi3 Venture Partners and First Leaside.
Who are eSight's competitors?
Competitors of eSight include SynergEyes, Ace Vision Group, .lumen, Biel Glasses, Optovue, IrisVision, Liberating Technologies, Bioness, Eyedaptic, Exogenesis and 34 more.
Compare eSight to Competitors
Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.
Biopticon Corporation is aimed to develop medical diagnostic devices using laser, photonics and image processing based technologies.
C2C is a medical device company developing a portfolio of medical devices.
Medical devices for the treatment of severe gastrointestinal disorders
OcuSciences is developing a product to use images from the eye to detect diseases such as diabetes at an earlier stage.
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.